These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10431778)

  • 1. Systemic sclerosis and multiple sclerosis.
    Spadaro A; Sensi F; Barrella M; Francia A
    J Neurol; 1999 Jun; 246(6):497-9. PubMed ID: 10431778
    [No Abstract]   [Full Text] [Related]  

  • 2. Infrequency of anticentromere antibody in patients without systemic sclerosis and without Raynaud's phenomenon.
    Migliaresi S; Picillo U; Terri G; Improta RD; La Palombara F; Giordano M
    Arthritis Rheum; 1987 Mar; 30(3):358-9. PubMed ID: 3494456
    [No Abstract]   [Full Text] [Related]  

  • 3. Prescleroderma: a distinct stage of systemic sclerosis.
    Amato L; Gallerani I; Berti S; Fabbri P
    Skinmed; 2003; 2(1):59-61. PubMed ID: 14673329
    [No Abstract]   [Full Text] [Related]  

  • 4. Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group.
    Avouac J; Fransen J; Walker UA; Riccieri V; Smith V; Muller C; Miniati I; Tarner IH; Randone SB; Cutolo M; Allanore Y; Distler O; Valentini G; Czirjak L; Müller-Ladner U; Furst DE; Tyndall A; Matucci-Cerinic M;
    Ann Rheum Dis; 2011 Mar; 70(3):476-81. PubMed ID: 21081523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic sclerosis (scleroderma) and multiple sclerosis.
    Trostle DC; Helfrich D; Medsger TA
    Arthritis Rheum; 1986 Jan; 29(1):124-7. PubMed ID: 3947408
    [No Abstract]   [Full Text] [Related]  

  • 6. Anticentromere antibodies in rheumatologic practice are not consistently associated with scleroderma.
    Tubach F; Hayem G; Elias A; Nicaise P; Haim T; Kahn MF; Meyer O
    Rev Rhum Engl Ed; 1997 Jun; 64(6):362-7. PubMed ID: 9513607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticentromere antibody and primary pulmonary hypertension.
    Seibold JR; Trontell MC
    J Rheumatol; 1982; 9(4):607-9. PubMed ID: 6752406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinico-immunological characteristics of the course of systemic scleroderma].
    Musaev SK; Speranskiĭ AI
    Ter Arkh; 1984; 56(5):42-5. PubMed ID: 6611599
    [No Abstract]   [Full Text] [Related]  

  • 9. [Systemic sclerosis autoantibodies: what dermatologists must know].
    Hüe S; Ingen-Housz-Oro S; Cosnes A
    Ann Dermatol Venereol; 2013 Feb; 140(2):143-9. PubMed ID: 23395500
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter: Antinuclear antibodies-clinical significance of the nuclear immunofluorescent patterns.
    Burnham TK; Bank PW
    Am J Clin Pathol; 1975 Aug; 64(2):289-90. PubMed ID: 1098444
    [No Abstract]   [Full Text] [Related]  

  • 11. [Raynaud disease].
    Pettersson T
    Duodecim; 2005; 121(22):2411-9. PubMed ID: 16457072
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anti-Scl-70 antibodies in systemic scleroderma].
    Le Thi Huong ; Sauvaget F; Johanet C; De Gennes C; Raguin G; Abuaf N; Blétry O; Guillevin L; Homberg JC; Godeau P
    Ann Dermatol Venereol; 1990; 117(2):103-7. PubMed ID: 2111650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anti-centromere antibody, biological marker of the CREST syndrome as distinct from scleroderma].
    Rouquette-Gally AM; Stern MH; Prost AC; Abuaf N; Homberg JC; Combrisson A
    Presse Med; 1985 Jul 13-20; 14(28):1497-500. PubMed ID: 2931679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current findings in progressive systemic sclerosis].
    Zanussi C; Ortolani C; Pastorello E; Riboldi PS; Sabbadini MG
    Minerva Med; 1982 Apr; 73(18):1189-200. PubMed ID: 7043320
    [No Abstract]   [Full Text] [Related]  

  • 15. Early diagnosis of systemic sclerosis.
    Jünger M; Schlez A; Steins A; Zuder D; Hahn M
    Adv Exp Med Biol; 1999; 455():111-3. PubMed ID: 10599331
    [No Abstract]   [Full Text] [Related]  

  • 16. Discoid lupus erythematosus in a patient with scleroderma and hepatitis C virus infection.
    Yamamoto M; Yamamoto T; Tsuboi R
    Rheumatol Int; 2010 May; 30(7):969-71. PubMed ID: 19543731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anticentromere antibody, CREST and cancer].
    Boyeldieu D; Rouquette-Gally AM; Laugier A; Abuaf N
    Presse Med; 1987 Nov; 16(38):1924-5. PubMed ID: 2962150
    [No Abstract]   [Full Text] [Related]  

  • 18. Case control study of antibodies to ENA in progressive systemic sclerosis patients.
    Furst DE; Obrodovic M; Barnett EV; Clements PJ; Paulus HE
    J Rheumatol; 1984 Jun; 11(3):298-305. PubMed ID: 6610753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A patient with systemic sclerosis, severe cytopenias and the simultaneous presence of anti-centromere and anti-SCL-70-antibodies.
    Hietarinta M; Tertti R; Lassila O
    Clin Exp Rheumatol; 1993; 11(4):457-8. PubMed ID: 8403594
    [No Abstract]   [Full Text] [Related]  

  • 20. Anticentromere antibody in patients without CREST and scleroderma: association with active digital vasculitis, rheumatic and connective tissue disease.
    Goldman JA
    Ann Rheum Dis; 1989 Sep; 48(9):771-5. PubMed ID: 2802800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.